CD274 and neoplasm: Although hyperprogression occurs in the settings of ICB treatment (PD1/PD‐L1 inhibitor treatment in particular) in most cases, patients receiving other therapeutic modalities showed similar tumor flares, including chemotherapy, radiotherapy, surgery, and targeted therapy.